7 Clinics · Kerala & Tamil Nadu · +91 80860 00608 · help@dermavue.com
Overview GLP-1 Injections Belly Fat Ozempic & Wegovy Mounjaro Generic GLP-1 Am I Eligible? PCOS Quiz Titration Tool Diet Plan Exercise Plan
Medical weight loss program at DermaVue clinics in Kerala and Tamil Nadu
DermaVue SuperHuman Medical Weight Loss Program
DermaVue SuperHuman Program Physician-Led GLP-1

Medical Weight Loss in India: Lose Belly Fat, Keep Your Muscle.

India's Leading Physician-Led GLP-1 Weight Loss Program. Doctor-supervised GLP-1 injections with Ozempic, Mounjaro & Wegovy across Kerala & Tamil Nadu.

RM
Dr. Rejeesh Menon, MD Medical Director, DermaVue Clinics
₹5,660/moStarting Price
7 ClinicsKerala & Tamil Nadu
4.8 / 57,200+ Reviews
20%+Weight Loss
Take the Free Eligibility Test
Quick Answer

Medical weight loss in India is doctor-supervised therapy that combines GLP-1 injections like Ozempic, Wegovy, and Mounjaro with nutrition coaching, resistance training, and metabolic monitoring. DermaVue Clinics runs the SuperHuman Program at 7 physician-led centres across Kerala and Tamil Nadu, with prices starting at ₹5,660 per month and protocols built for the thin-fat Indian phenotype.

Clinical Summary

The DermaVue Clinics medical team developed the SuperHuman Program around the South Asian thin-fat phenotype, where visceral fat is high even at normal BMI. The protocol combines doctor-prescribed GLP-1 therapy with a 1.2 to 1.6 g/kg protein target, structured resistance training, and monthly metabolic review. Treatment is delivered across 7 physician-led DermaVue centres in Kerala and Tamil Nadu, with over 7,200 patient reviews and a 4.8 average star rating. The program focuses on muscle preservation and visceral fat loss, not scale weight alone.

IADVL Registered
US-FDA Approved
Board-Certified Physicians
10+ Years Experience
Board-Certified Medical Weight Loss

DermaVue SuperHuman is a physician-supervised medical weight loss program operating across seven board-certified dermatology clinics in Kerala and Tamil Nadu, India. The program uses US-FDA approved GLP-1 receptor agonists including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro), combined with clinical dietitian support, body composition monitoring, and a proprietary Face-Saver dermatology protocol. Founded by Dr. Rejeesh Menon MD and Dr. Sarath Chandran MD DVL, DermaVue maintains a 4.8-star rating from over 7,200 patient reviews. Semaglutide programs start at INR 5,660 per month with locations in Thiruvananthapuram, Kollam, Thiruvalla, Kottayam, Kochi, Thrissur, and Coimbatore.

The Science

Why Indians Gain Weight Differently

Indian phenotype visceral fat comparison showing thin-fat Indian body composition

The “Thin-Fat Indian” Problem

Research shows one-third of Indians with “normal” weight carry dangerous levels of hidden visceral fat. At the same BMI, Indians have significantly higher body fat percentage than Europeans. Placing them at elevated risk for diabetes, heart disease, and metabolic syndrome.

21.2%
Indian body fat (BMI 22.3)
9.1%
European body fat (BMI 22.3)

Same BMI. Completely different health risk.

Source: Yajnik CS, The Lancet, 2004. “The thin-fat Indian baby: differences in body composition and metabolic risk.”

Know Your Numbers

The New Indian BMI Standards

Indian-specific BMI cutoffs are lower than international standards. Because Indians develop metabolic complications at lower body weight.

Category Indian Cutoff International (WHO)
NormalBelow 23Below 25
Overweight23-24.925-29.9
Obese25 and above30 and above

Important: Even if your BMI is normal, you may still be at high metabolic risk. BMI alone does not reveal visceral fat, insulin resistance, or metabolic syndrome. A clinical assessment is essential.

Take the Free GLP-1 Eligibility Test Or Book a Consultation

3 minutes. Physician-designed. Your data stays private.

The Program

The SuperHuman 3-Pillar Program

Not a diet. Not a gym plan. A medically supervised system that addresses the root causes of weight gain in the Indian body.

Pillar 1

Pillar 1: Medical (GLP-1 Therapy)

Physician-prescribed GLP-1 receptor agonist injections (Mounjaro or Ozempic) with structured dose titration, monthly medical review, and body composition tracking. Targets visceral belly fat at the hormonal level.

Pillar 2

Pillar 2: Nutrition (Clinical Dietitian)

45 to 60 minute initial dietitian assessment followed by weekly check-ins. Protein optimization at 1.2 to 1.6 g/kg ideal body weight, Indian meal planning, and macro tracking to preserve lean muscle during fat loss.

Pillar 3

Pillar 3: Movement (Exercise Guidance)

Structured resistance training protocol designed to prevent the muscle loss that affects up to 45% of unsupervised GLP-1 weight loss. Creatine supplementation guidance and progressive overload tracking.

The Mechanism

How GLP-1 Works in the Indian Body

GLP-1 receptor agonists work through multiple biological pathways to address the specific metabolic challenges faced by Indian patients.

Appetite Regulation

GLP-1 acts on the hypothalamus to reduce hunger signals, making it easier to maintain a caloric deficit without the constant willpower battle. Patients report feeling satisfied with smaller portions within the first 2 weeks.

Visceral Fat Targeting

Unlike dieting alone, GLP-1 medications preferentially reduce visceral (belly) fat. The metabolically dangerous fat that wraps around organs and drives insulin resistance in the Indian thin-fat phenotype.

Insulin Sensitivity

GLP-1 improves pancreatic beta-cell function and enhances insulin sensitivity, directly addressing the insulin resistance that is disproportionately common in South Asian populations even at lower BMI levels.

Gastric Slowing

By slowing gastric emptying, GLP-1 extends the feeling of fullness after meals, reduces post-meal blood sugar spikes, and helps patients naturally eat less. Particularly effective with traditional Indian carb-heavy meals.

Dermatologist-supervised GLP-1 weight loss program at DermaVue preventing Ozempic face
DermaVue's dermatology advantage. Skin protection built into every weight loss program
Treatment Options

Which Medication Is Right for You?

Your physician will recommend the optimal GLP-1 medication based on your metabolic profile, health history, and treatment goals.

First-Line Recommendation

Tirzepatide (Mounjaro)

  • ✓ Dual GIP + GLP-1 receptor agonist
  • ✓ Up to 22.5% weight loss (SURMOUNT-1 trial)
  • ✓ Superior for visceral fat reduction in Indian patients
  • ✓ Weekly injection. Physician-administered or self-injection
Learn About Mounjaro

Semaglutide (Ozempic / Wegovy)

  • ✓ Single GLP-1 receptor agonist
  • ✓ Up to 14.9% weight loss (STEP 1 trial)
  • ✓ Proven safety profile since 2017
  • ✓ Also available as oral tablet (Rybelsus) for maintenance
Learn About Ozempic & Wegovy
Transparent Pricing

GLP-1 Medication Starting Prices

Doctor-supervised programs with transparent medication pricing. No hidden fees.

Entry Tier

Semaglutide

Ozempic · Wegovy · Generic options

₹5,660/month starting

Starting dose. Dose escalation pricing discussed during your consultation. Multiple generic options now available in India.

Learn About Semaglutide
Most Effective

Tirzepatide (Mounjaro)

Dual GIP/GLP-1 · Most effective option

₹13,000/month starting

Starting dose. Up to 22.5% weight loss in clinical trials. Dose escalation pricing discussed during consultation.

Learn About Mounjaro

Generic GLP-1 medications are rapidly entering the Indian market, making treatment more accessible. Pricing will be updated as new options become available. Consultation and program fees are discussed separately.

Book Your Consultation
Your Protocol

What Happens After You Book?

From first inquiry to visible results, here is your step-by-step path through the SuperHuman Program.

1

WhatsApp / Online Inquiry

Reach out via WhatsApp or our booking form. Our coordinator will collect basic health details and schedule your first consultation.

2

Dietitian Consultation (45 to 60 min)

A full nutrition and lifestyle assessment covering diet history, eating patterns, activity level, and metabolic risk screening.

3

Mandatory Lab Panel

HbA1c, Fasting Insulin, HOMA-IR, Complete Lipids, TSH, LFT, eGFR, Vitamin D3, and B12. Lab form sent after the dietitian consultation.

4

Dermatologist Medical Clearance

Your dermatologist reviews labs, assesses skin health baseline, and confirms GLP-1 eligibility with a personalized dosing plan.

5

GLP-1 Therapy Initiation + Monthly Monitoring

Start Mounjaro (Tirzepatide) or Ozempic (Semaglutide) at the lowest effective dose with structured titration under medical supervision. Monthly body composition tracking ensures you lose fat, not muscle.

Book Your SuperHuman Consultation

Generic GLP-1 Update. March 2026

Generic semaglutide entered the Indian market in March 2026. Branded Ozempic at 0.5 mg weekly previously ran around Rs 8,100 per month. Indian generics from Natco, Alkem, and Dr. Reddy's now sit between Rs 1,290 and Rs 4,200 at the same dose. The molecule and safety profile are identical. Physician supervision is still required because GLP-1 therapy carries real contraindications. Cheaper does not mean safer to self-prescribe.

Read the full generic GLP-1 India guide →

Related Resources

Continue Reading

GLP-1 Injections

How GLP-1 therapy targets belly fat in Indian patients.

Am I Eligible for GLP-1?

Free 3-minute physician-designed eligibility test for GLP-1.

Generic Semaglutide India 2026

Brand-by-brand pricing guide to Indian GLP-1 generics.
Complete Resource Library

Every SuperHuman Tool, Protocol and Guide

A physician-built resource map covering medications, interactive tools, protocols, and Indian lifestyle plans across the DermaVue SuperHuman programme.

Medications and Comparisons

Visceral Fat and Thin-Fat Phenotype Guide

How belly fat reduction works in the South Asian thin-fat phenotype, with imaging and metabolic markers.

Fat Burner vs GLP-1 Comparison

A side-by-side clinical comparison of OTC fat burners and physician-prescribed GLP-1 therapy.

18-Trial GLP-1 Clinical Evidence Library

STEP, SURMOUNT, SELECT, FLOW and the full set of trials behind every DermaVue SuperHuman protocol.

Interactive Tools

PCOS Insulin Resistance Risk Assessment

A 2-minute physician-built quiz to check insulin resistance risk in Indian women with PCOS.

GLP-1 Dose Titration Protocol Tool

The safe semaglutide and tirzepatide dose escalation schedule used in DermaVue clinics.

Calorie Deficit Calculator for Indians

BMR, TDEE and a safe daily calorie target tuned to Indian body composition.

Protocols and Lifestyle

Physician Food List for Indians

The full DermaVue weight loss food list with kcal, protein and glycaemic load from ICMR-NIN data.

7-Day Kerala Meal Plan

A ready-to-follow 7-day Indian meal template with non-veg and vegetarian variants.

Weight Loss for Women in India

Hormone-aware metabolic care for PCOS, post-partum and menopause weight gain.

PCOS and GLP-1 Deep Dive

How semaglutide and tirzepatide treat PCOS-driven insulin resistance and hyperandrogenism.

GLP-1 Side Effect Management Protocol

Step-by-step physician protocol for nausea, reflux and constipation on GLP-1 therapy.

Complete GLP-1 Side Effects Guide

Common, serious and rare side effects of semaglutide and tirzepatide with red-flag triage.
Common Questions

Frequently Asked Questions

The SuperHuman Program is DermaVue's dermatologist-led, dietitian-supported medical weight loss program combining GLP-1 medications (Mounjaro/Tirzepatide or Ozempic/Semaglutide) with dermatologist skin protection, body composition monitoring, and nutrition guidance.

Patients with BMI ≥25 (Indian standard), or BMI 23 to 27 with metabolic risk factors such as prediabetes, high waist circumference, PCOS, or fatty liver. A doctor assessment determines eligibility after lab review.

Mounjaro (Tirzepatide) activates both GIP and GLP-1 receptors (dual mechanism), achieving up to 22.5% weight loss in the SURMOUNT-1 trial. Ozempic (Semaglutide) activates only GLP-1 receptors, achieving up to 14.9% in the STEP 1 trial. DermaVue recommends Mounjaro as first-line for most patients.

Start with a WhatsApp inquiry or book a consultation. Your first step is a 45 to 60 minute dietitian assessment, followed by a mandatory lab panel. Once labs are reviewed, your dermatologist creates a personalized GLP-1 treatment plan. The entire onboarding takes about 1 to 2 weeks.

Ozempic Face refers to facial volume loss that can occur with rapid weight loss on GLP-1 therapy. DermaVue's Face-Saver Protocol uses Profhilo bioremodeling at Month 2, Polynucleotides at Month 3, and MFU-V/Ultherapy from Month 6 to prevent and restore facial volume.

Yes, with appropriate medical screening. Indian consensus guidelines define overweight as BMI ≥23. GLP-1 therapy is particularly effective for the Indian thin-fat phenotype with central obesity and metabolic risk at normal Western BMI cutoffs.

Baseline labs include HbA1c, Fasting Insulin, HOMA-IR calculation, Complete Lipid Panel, TSH, LFT (ALT/AST), Kidney Function (eGFR), Vitamin D3, and B12. The lab form is sent after the dietitian consultation.

Without proper supervision, up to 45% of GLP-1 weight loss can be lean muscle. DermaVue's SuperHuman Program prevents this through protein optimization (1.2 to 1.6 g/kg ideal body weight), resistance training guidance, creatine supplementation, and monthly body composition tracking.

7 Locations Across South India

Visit Any of Our 7 Clinics

Or book a teleconsultation from anywhere in India

Thiruvananthapuram
Kerala
★ 4.7 (1309+)
+91 83308 60007
Kollam
Kerala
★ 4.9 (370+)
+91 80868 60465
Thiruvalla
Kerala
★ 4.8 (3221+)
+91 80860 00608
Kottayam
Kerala
★ 4.8 (558+)
+91 81298 83331
Aluva
Kerala
★ 4.8 (1438+)
+91 90720 07733
Thrissur
Kerala
★ 4.9 (262+)
+91 73567 42225
Coimbatore
Tamil Nadu
★ 4.9 (123+)
+91 80868 60018
Book In-Clinic Consultation WhatsApp for Teleconsultation

Reviewed by Dr. Rejeesh Menon, MD · Last updated 7 April 2026

Start Your Transformation

Ready to Begin?

Book a consultation at any of our 7 clinics, or start with a WhatsApp inquiry from anywhere in India. Your physician-supervised weight loss program starts with one conversation.

WhatsApp Us to Get Started Book In-Clinic Consultation